Literature DB >> 29180531

Anion Gap as a Determinant of Ionized Fraction of Divalent Cations in Hemodialysis Patients.

Yusuke Sakaguchi1, Takayuki Hamano2, Keiichi Kubota3, Tatsufumi Oka3, Satoshi Yamaguchi3, Ayumi Matsumoto3, Nobuhiro Hashimoto3, Daisuke Mori3, Yasue Obi4, Isao Matsui3, Yoshitaka Isaka3.   

Abstract

BACKGROUND AND OBJECTIVES: Circulating levels of anions that bind to magnesium and calcium are often altered in patients with CKD. However, it is unknown how these alterations affect the ionized fraction of magnesium and calcium. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This cross-sectional study involved patients on maintenance hemodialysis and patients not on dialysis who visited the outpatient department of nephrology. We collected whole-blood samples to measure ionized magnesium and calcium concentrations. Adjusted anion gap was calculated as an integrative index of unmeasured anions.
RESULTS: A total of 118 patients on hemodialysis and 112 patients not on dialysis were included. Although the prevalence of hypermagnesemia defined by total magnesium was much higher in patients on hemodialysis than in patients not on dialysis (69% versus 12%; P<0.001), the prevalence of hypermagnesemia defined by ionized magnesium did not differ significantly (13% versus 18%; P=0.28). Among patients on hemodialysis with high total magnesium, 83% had normal or low ionized magnesium. Consequently, the mean ionized fraction of magnesium in patients on hemodialysis was significantly lower than that in patients not on dialysis (51% versus 63%; P<0.001). Similarly, the mean ionized fraction of calcium in patients on hemodialysis was lower than that in patients not on dialysis (55% versus 56%; P<0.001). In patients on hemodialysis who had a higher adjusted anion gap than patients not on dialysis (mean [SD]: 14.1 [2.2] versus 5.1 [3.1]), the ionized fractions of magnesium and calcium were inversely associated with the adjusted anion gap. Furthermore, the anion gap significantly improved predictions of ionized magnesium and calcium in patients on hemodialysis.
CONCLUSIONS: Anions that accumulate in patients on hemodialysis contribute to the lower ionized fraction of magnesium and calcium. Equations that incorporate the anion gap provide better predictions of ionized magnesium and calcium in patients on hemodialysis.
Copyright © 2018 by the American Society of Nephrology.

Entities:  

Keywords:  Acid-Base Equilibrium; Anions; Cations, Divalent; Cross-Sectional Studies; Fluid Therapy; Kidney Failure, Chronic; Magnesium; Metabolic Diseases; Outpatients; Prevalence; calcium; chronic kidney disease; hemodialysis; renal dialysis

Mesh:

Substances:

Year:  2017        PMID: 29180531      PMCID: PMC5967434          DOI: 10.2215/CJN.07930717

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  34 in total

1.  Serum phosphate is an important determinant of corrected serum calcium in end-stage kidney disease.

Authors:  Paolo Ferrari; Richard Singer; Aanchal Agarwal; Anne Hurn; Mary A Townsend; Paul Chubb
Journal:  Nephrology (Carlton)       Date:  2009-06       Impact factor: 2.506

2.  Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study.

Authors:  Rika Ago; Toshihiro Shindo; Masataka Banshodani; Sadanori Shintaku; Misaki Moriishi; Takao Masaki; Hideki Kawanishi
Journal:  Hemodial Int       Date:  2016-06-21       Impact factor: 1.812

3.  Hypomagnesemia and Mortality in Incident Hemodialysis Patients.

Authors:  Lin Li; Elani Streja; Connie M Rhee; Rajnish Mehrotra; Melissa Soohoo; Steven M Brunelli; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2015-07-14       Impact factor: 8.860

4.  Serum magnesium concentration is a significant predictor of mortality in peritoneal dialysis patients.

Authors:  Paula Fein; Stacey Weiss; Francis Ramos; Priyanka Singh; Jyotiprakas Chattopadhyay; Morrell M Avram
Journal:  Adv Perit Dial       Date:  2014

5.  Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study.

Authors:  Eduardo Lacson; Weiling Wang; Lin Ma; Jutta Passlick-Deetjen
Journal:  Am J Kidney Dis       Date:  2015-07-17       Impact factor: 8.860

6.  Lower serum magnesium is associated with cardiovascular risk factors and mortality in haemodialysis patients.

Authors:  Patrícia João Matias; Ana Azevedo; Ivo Laranjinha; David Navarro; Marco Mendes; Carina Ferreira; Tiago Amaral; Cristina Jorge; Inês Aires; Célia Gil; Aníbal Ferreira
Journal:  Blood Purif       Date:  2015-01-06       Impact factor: 2.614

7.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

Review 8.  Mechanistic insights into vascular calcification in CKD.

Authors:  Rukshana Shroff; David A Long; Catherine Shanahan
Journal:  J Am Soc Nephrol       Date:  2012-11-08       Impact factor: 10.121

9.  Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.

Authors:  Jürgen Floege; Joseph Kim; Elizabeth Ireland; Charles Chazot; Tilman Drueke; Angel de Francisco; Florian Kronenberg; Daniele Marcelli; Jutta Passlick-Deetjen; Guntram Schernthaner; Bruno Fouqueray; David C Wheeler
Journal:  Nephrol Dial Transplant       Date:  2010-04-25       Impact factor: 5.992

Review 10.  Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies.

Authors:  Yusuke Sakaguchi; Takayuki Hamano; Yoshitaka Isaka
Journal:  Nutrients       Date:  2017-02-06       Impact factor: 5.717

View more
  4 in total

Review 1.  Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials.

Authors:  Juan R Muñoz-Castañeda; María V Pendón-Ruiz de Mier; Mariano Rodríguez; María E Rodríguez-Ortiz
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

Review 2.  The emerging role of magnesium in CKD.

Authors:  Yusuke Sakaguchi
Journal:  Clin Exp Nephrol       Date:  2022-01-25       Impact factor: 2.617

3.  Dietary magnesium and risk of cardiovascular and all-cause mortality after myocardial infarction: A prospective analysis in the Alpha Omega Cohort.

Authors:  Ilse Evers; Esther Cruijsen; Iris Kornaat; Renate M Winkels; Maria C Busstra; Johanne M Geleijnse
Journal:  Front Cardiovasc Med       Date:  2022-08-12

Review 4.  The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce.

Authors:  Louise McAlister; Pearl Pugh; Laurence Greenbaum; Dieter Haffner; Lesley Rees; Caroline Anderson; An Desloovere; Christina Nelms; Michiel Oosterveld; Fabio Paglialonga; Nonnie Polderman; Leila Qizalbash; José Renken-Terhaerdt; Jetta Tuokkola; Bradley Warady; Johan Vande Walle; Vanessa Shaw; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2019-10-30       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.